Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen O Brennan

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
Clinical Chemistry|December 28, 2007
Fifty-eight years of hemoglobin analysisStephen O Brennan
BBA Clinical|December 18, 2015
Variation of fibrinogen oligosaccharide structure in the acute phase response: Possible haemorrhagic implicationsStephen O Brennan
Clinical Biochemistry|October 4, 2015
Acquired and congenital fast albumin bands; insights from electrospray TOF analysis of whole plasma into drug binding and albumin recyclingStephen O Brennan, Richard Mackay
Clinical Chemistry|October 9, 2007
Modified form of the fibrinogen Bbeta chain (des-Gln Bbeta), a potential long-lived marker of pancreatitisDavid Schmidt, Stephen O Brennan
Hemoglobin|April 1, 2010
Hb Perpignan [beta136(H14)Gly-->Ser], a silent variant associated with normal hematologyStephen O Brennan, Tim Chan
Thrombosis and Haemostasis|March 8, 2013
Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations (γ114Tyr→His, and γ320Asp deleted)Stephen O Brennan, Meera Chitlur
Thrombosis Research|July 22, 2014
Functionally compromised FGG variant (γ320Asp→Glu) expressed at low level in plasma fibrinogenStephen O Brennan, Andrew Laurie
Hemoglobin|June 29, 2013
Hb Papanui [α99(G8)Lys→Arg; HBA2: c.299A>G]: a novel silent substitution interfering in Hb A1c determinationStephen O Brennan, Tim Chan
Thrombosis and Haemostasis|June 30, 2011
Novel fibrinogen (B β401Gly→Val) presents as dys- or hypodysfibrinogenaemia due to alterations in sialic acid contentStephen O Brennan, Fernando Roncolato
Thrombosis and Haemostasis|November 15, 2007
Fibrinogen Tolaga Bay: a novel gammaAla341Val mutation causing hypofibrinogenaemiaRyan L Davis, Stephen O Brennan
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
Clinical Chemistry|December 28, 2007
Fifty-eight years of hemoglobin analysisStephen O Brennan
BBA Clinical|December 18, 2015
Variation of fibrinogen oligosaccharide structure in the acute phase response: Possible haemorrhagic implicationsStephen O Brennan
Clinical Biochemistry|October 4, 2015
Acquired and congenital fast albumin bands; insights from electrospray TOF analysis of whole plasma into drug binding and albumin recyclingStephen O Brennan, Richard Mackay
Clinical Chemistry|October 9, 2007
Modified form of the fibrinogen Bbeta chain (des-Gln Bbeta), a potential long-lived marker of pancreatitisDavid Schmidt, Stephen O Brennan
Hemoglobin|April 1, 2010
Hb Perpignan [beta136(H14)Gly-->Ser], a silent variant associated with normal hematologyStephen O Brennan, Tim Chan
Thrombosis and Haemostasis|March 8, 2013
Hypodysfibrinogenaemia and thrombosis in association with a new fibrinogen γ chain with two mutations (γ114Tyr→His, and γ320Asp deleted)Stephen O Brennan, Meera Chitlur
Thrombosis Research|July 22, 2014
Functionally compromised FGG variant (γ320Asp→Glu) expressed at low level in plasma fibrinogenStephen O Brennan, Andrew Laurie
Hemoglobin|June 29, 2013
Hb Papanui [α99(G8)Lys→Arg; HBA2: c.299A>G]: a novel silent substitution interfering in Hb A1c determinationStephen O Brennan, Tim Chan
Thrombosis and Haemostasis|June 30, 2011
Novel fibrinogen (B β401Gly→Val) presents as dys- or hypodysfibrinogenaemia due to alterations in sialic acid contentStephen O Brennan, Fernando Roncolato
Thrombosis and Haemostasis|November 15, 2007
Fibrinogen Tolaga Bay: a novel gammaAla341Val mutation causing hypofibrinogenaemiaRyan L Davis, Stephen O Brennan
Pageof 10